Giuliano Marchetti
Research Subjects
Giuliano Marchetti has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Vittori
Department of Anesthesia, Critical Care and Pain Medicine, ARCO, Ospedale Pediatrico Bambino Gesù IRCCS, Piazza S. Onofrio 4, 00165 Rome, Italy
13 shared publications - Elisa Francia
Department of Anesthesia, Critical Care and Pain Medicine, ARCO, Ospedale Pediatrico Bambino Gesù IRCCS, Piazza S. Onofrio 4, 00165 Rome, Italy
9 shared publications - Franco Marinangeli
Department of Life, Health and Environmental Sciences (MeSVA), University of L’Aquila, Piazzale Salvatore Tommasi 1, Blocco 11, Coppito, 67010 L’Aquila, Italy
7 shared publications - Ilaria Mascilini
Department of Anesthesia, Critical Care and Pain Medicine, ARCO, Ospedale Pediatrico Bambino Gesù IRCCS, Piazza S. Onofrio 4, 00165 Rome, Italy
7 shared publications - Marco Cascella
Department of Medicine, Surgery and Dentistry, University of Salerno, 84081 Baronissi, Italy
6 shared publications - Corrado Cecchetti
Department of Anesthesia, Critical Care and Pain Medicine, ARCO, Ospedale Pediatrico Bambino Gesù IRCCS, Piazza S. Onofrio 4, 00165 Rome, Italy
5 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (14) , 2228
Hydromorphone in Pediatric Pain Management: Pharmacology, Clinical Applications, and Safety Considerations—A Narrative Review
Background: Pain is one of the most common and challenging clinical problems in pediatric care, affecting up to three-quarters of hospitalized children. Hydromorphone has gained increasing clinical interest as an alternative opioid in pediatric settings, although evidence supporting its use remains limited. Methods: A narrative literature review was conducted in accordance with SANRA recommendations using PubMed, Embase, and the Cochrane Library to identify studies evaluating hydromorphone use in pediatric and adolescent patients across perioperative, postoperative, intensive care unit (ICU), and emergency settings. Results: Available evidence suggests that hydromorphone may provide effective analgesia in pediatric patients across multiple clinical contexts, including postoperative pain control, patient-controlled analgesia, analgosedation in the ICU, and acute pain management in the emergency department. However, the available data are largely derived from small, heterogeneous, and predominantly retrospective studies, often limited to single-center experiences. Conclusions: Hydromorphone may represent a useful alternative opioid for pediatric pain management and analgosedation, particularly when morphine is ineffective or poorly tolerated. Nevertheless, the current evidence base is limited, heterogeneous, and largely observational, precluding robust conclusions regarding its comparative effectiveness and safety. Further well-designed pediatric studies are required to better define its role in clinical practice.
- 22 July 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (14) , 2228
Open AccessHydromorphone in Pediatric Pain Management: Pharmacology, Clinical Applications, and Safety Considerations—A Narrative Review
Background: Pain is one of the most common and challenging clinical problems in pediatric care, affecting up to three-quarters of hospitalized children. Hydromorphone has gained increasing clinical interest as an alternative opioid in pediatric settings, although evidence supporting its use remains limited. Methods: A narrative literature review was conducted in accordance with SANRA recommendations using PubMed, Embase, and the Cochrane Library to identify studies evaluating hydromorphone use in pediatric and adolescent patients across perioperative, postoperative, intensive care unit (ICU), and emergency settings. Results: Available evidence suggests that hydromorphone may provide effective analgesia in pediatric patients across multiple clinical contexts, including postoperative pain control, patient-controlled analgesia, analgosedation in the ICU, and acute pain management in the emergency department. However, the available data are largely derived from small, heterogeneous, and predominantly retrospective studies, often limited to single-center experiences. Conclusions: Hydromorphone may represent a useful alternative opioid for pediatric pain management and analgosedation, particularly when morphine is ineffective or poorly tolerated. Nevertheless, the current evidence base is limited, heterogeneous, and largely observational, precluding robust conclusions regarding its comparative effectiveness and safety. Further well-designed pediatric studies are required to better define its role in clinical practice.
- Open Access
- 15 May 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (10) , 1357
High Fidelity Simulations to Improve Pediatric Airway Management: A Narrative Review
High-fidelity simulations have become an important aid in clinical practice and research. In the pediatric field, they allow for the creation of scenarios involving emergency situations, in which decision-making algorithms must be rapidly applied, as is the case with airway management. Our narrative review examines articles in English indexed in PubMed, using the following search terms: high-fidelity simulation, pediatric, difficult airway management, bag mask ventilation, intubation, mechanical ventilation, tracheostomy, cricothyrotomy, laryngoscopy, fiberoptic bronchoscopy, and emergency situations. Airway management, along with venous access management, has always been one of the most challenging issues in pediatric anesthesia. The scarcity of patients and procedures, combined with the need to ensure high quality standards, necessitates simulations. Using high-performance devices and realistic settings allows us to reproduce not only the desired technical scenario, but also the emotions and group dynamics. High-fidelity simulations therefore prove to be an excellent aid for pediatric airway management, enhancing the hard and soft skills of both the team and the individual. Simulations allow us to replicate scenarios that are uncommon in clinical practice but have a significant impact due to their potential severity.
- 15 May 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (10) , 1357
Open AccessHigh Fidelity Simulations to Improve Pediatric Airway Management: A Narrative Review
High-fidelity simulations have become an important aid in clinical practice and research. In the pediatric field, they allow for the creation of scenarios involving emergency situations, in which decision-making algorithms must be rapidly applied, as is the case with airway management. Our narrative review examines articles in English indexed in PubMed, using the following search terms: high-fidelity simulation, pediatric, difficult airway management, bag mask ventilation, intubation, mechanical ventilation, tracheostomy, cricothyrotomy, laryngoscopy, fiberoptic bronchoscopy, and emergency situations. Airway management, along with venous access management, has always been one of the most challenging issues in pediatric anesthesia. The scarcity of patients and procedures, combined with the need to ensure high quality standards, necessitates simulations. Using high-performance devices and realistic settings allows us to reproduce not only the desired technical scenario, but also the emotions and group dynamics. High-fidelity simulations therefore prove to be an excellent aid for pediatric airway management, enhancing the hard and soft skills of both the team and the individual. Simulations allow us to replicate scenarios that are uncommon in clinical practice but have a significant impact due to their potential severity.
- Open Access
Advantages of Remimazolam in Pediatric Anesthesia: A Narrative Review
Remimazolam is an ultra-short-acting benzodiazepine developed according to the “soft drug” concept and characterized by rapid onset, predictable offset, organ-independent metabolism, and the availability of a specific antagonist. Due to these pharmacological features, this drug represents a particularly attractive option for pediatric anesthesia and sedation, a field in which traditional agents are often limited by hemodynamic instability, prolonged recovery, and adverse respiratory effects. This narrative review summarizes and discusses the current evidence regarding the use of remimazolam in pediatric patients, focusing on pharmacokinetics, pharmacodynamics, clinical applications, and safety. Available data indicate that remimazolam provides effective sedation and anesthesia in children across multiple settings, including induction of general anesthesia, non-operating room anesthesia, and intensive care unit sedation. Compared with propofol and midazolam, remimazolam is generally associated with greater hemodynamic stability, rapid recovery, reduced emergence delirium, and a favorable respiratory profile, while maintaining comparable efficacy. Intranasal administration has also shown promise as a premedication strategy for reducing preoperative anxiety, although it may occasionally be associated with pain. Even if remimazolam lacks intrinsic analgesic properties, its use appears to indirectly improve postoperative comfort by attenuating stress responses and emergence agitation. Despite encouraging results, pediatric use of remimazolam remains off-label in many countries, and evidence is still limited by small sample sizes and heterogeneous protocols. Further large-scale randomized controlled trials are needed to define optimal dosing strategies, long-term safety, and their definitive role in pediatric anesthetic and sedative practice.
Open AccessAdvantages of Remimazolam in Pediatric Anesthesia: A Narrative Review
Remimazolam is an ultra-short-acting benzodiazepine developed according to the “soft drug” concept and characterized by rapid onset, predictable offset, organ-independent metabolism, and the availability of a specific antagonist. Due to these pharmacological features, this drug represents a particularly attractive option for pediatric anesthesia and sedation, a field in which traditional agents are often limited by hemodynamic instability, prolonged recovery, and adverse respiratory effects. This narrative review summarizes and discusses the current evidence regarding the use of remimazolam in pediatric patients, focusing on pharmacokinetics, pharmacodynamics, clinical applications, and safety. Available data indicate that remimazolam provides effective sedation and anesthesia in children across multiple settings, including induction of general anesthesia, non-operating room anesthesia, and intensive care unit sedation. Compared with propofol and midazolam, remimazolam is generally associated with greater hemodynamic stability, rapid recovery, reduced emergence delirium, and a favorable respiratory profile, while maintaining comparable efficacy. Intranasal administration has also shown promise as a premedication strategy for reducing preoperative anxiety, although it may occasionally be associated with pain. Even if remimazolam lacks intrinsic analgesic properties, its use appears to indirectly improve postoperative comfort by attenuating stress responses and emergence agitation. Despite encouraging results, pediatric use of remimazolam remains off-label in many countries, and evidence is still limited by small sample sizes and heterogeneous protocols. Further large-scale randomized controlled trials are needed to define optimal dosing strategies, long-term safety, and their definitive role in pediatric anesthetic and sedative practice.
- Open Access
- 4 February 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 358
Cannabinoid Effects of Metamizol/Dipyrone: A Possible Second Life in Pediatric Anesthesia for a Vintage Drug
Background: Metamizol (dipyrone) is a widely used analgesic and antipyretic drug in several European countries, particularly for postoperative pain management in both adult and pediatric populations. Methods: A narrative literature review was conducted to evaluate the efficacy, safety, and pharmacological mechanisms of metamizol in postoperative pain management. A comprehensive search of PubMed, Scopus, and the Cochrane Library was performed, and included articles published up to 2024. Search terms included metamizol, dipyrone and children. Results: The available evidence indicates that metamizol provides effective postoperative analgesia, with an efficacy comparable to that of other non-steroidal anti-inflammatory drugs and paracetamol. Pediatric studies similarly support its effectiveness in postoperative settings. Regarding safety, short-term use of metamizol appears to be well tolerated, with a low incidence of serious adverse events. Mechanistic studies suggest that metamizol exerts analgesic effects through a multimodal pathway, involving not only cyclo-oxygenase inhibition but also modulation of opioid and endocannabinoid systems. Conclusions: Metamizol represents an effective and generally well-tolerated option for short-term postoperative pain management in both adults and children when used under appropriate clinical monitoring. Current evidence supports a favorable benefit-to-risk balance for short-term use while highlighting the need for caution during prolonged therapy. Further large-scale, prospective studies are warranted to better define rare adverse events, clarify interindividual risk factors, and refine the understanding of their non-classical mechanisms of action.
- 4 February 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 358
Open AccessCannabinoid Effects of Metamizol/Dipyrone: A Possible Second Life in Pediatric Anesthesia for a Vintage Drug
Background: Metamizol (dipyrone) is a widely used analgesic and antipyretic drug in several European countries, particularly for postoperative pain management in both adult and pediatric populations. Methods: A narrative literature review was conducted to evaluate the efficacy, safety, and pharmacological mechanisms of metamizol in postoperative pain management. A comprehensive search of PubMed, Scopus, and the Cochrane Library was performed, and included articles published up to 2024. Search terms included metamizol, dipyrone and children. Results: The available evidence indicates that metamizol provides effective postoperative analgesia, with an efficacy comparable to that of other non-steroidal anti-inflammatory drugs and paracetamol. Pediatric studies similarly support its effectiveness in postoperative settings. Regarding safety, short-term use of metamizol appears to be well tolerated, with a low incidence of serious adverse events. Mechanistic studies suggest that metamizol exerts analgesic effects through a multimodal pathway, involving not only cyclo-oxygenase inhibition but also modulation of opioid and endocannabinoid systems. Conclusions: Metamizol represents an effective and generally well-tolerated option for short-term postoperative pain management in both adults and children when used under appropriate clinical monitoring. Current evidence supports a favorable benefit-to-risk balance for short-term use while highlighting the need for caution during prolonged therapy. Further large-scale, prospective studies are warranted to better define rare adverse events, clarify interindividual risk factors, and refine the understanding of their non-classical mechanisms of action.
- Open Access
Advantages of Ciprofol with Special Consideration of Pediatric Anesthesia
The search for an ideal anesthetic has always been a major goal in anesthesiology. In recent years, the introduction of ciprofol has marked a major breakthrough in the pharmacological field, following the introduction of dexmedetomidine. Ciprofol has similar characteristics to propofol but with greater hemodynamic stability. Furthermore, it overcomes one of the most common discomforts associated with propofol: pain at the injection site. These characteristics make it a suitable hypnotic for pediatric use. Although studies on children are still limited, the literature on adults is now substantial and of high quality. The potential advantages of using ciprofol in pediatric anesthesia include pain-free induction, hemodynamic stability, less respiratory depression, and a lower incidence of emergence delirium.
Open AccessAdvantages of Ciprofol with Special Consideration of Pediatric Anesthesia
The search for an ideal anesthetic has always been a major goal in anesthesiology. In recent years, the introduction of ciprofol has marked a major breakthrough in the pharmacological field, following the introduction of dexmedetomidine. Ciprofol has similar characteristics to propofol but with greater hemodynamic stability. Furthermore, it overcomes one of the most common discomforts associated with propofol: pain at the injection site. These characteristics make it a suitable hypnotic for pediatric use. Although studies on children are still limited, the literature on adults is now substantial and of high quality. The potential advantages of using ciprofol in pediatric anesthesia include pain-free induction, hemodynamic stability, less respiratory depression, and a lower incidence of emergence delirium.
- 1 March 2024
- Published by Edizioni Minerva Medica in Chirurgia
- Vol. 37 (1) , 52-53
Acupuncture as a peacekeeper between anesthesiologist and surgeon
Article: Acupuncture as a peacekeeper between anesthesiologist and surgeon - Chirurgia 2024 February;37(1):52-3 - Minerva Medica - Journals
- 1 March 2024
- Published by Edizioni Minerva Medica in Chirurgia
- Vol. 37 (1) , 52-53
Acupuncture as a peacekeeper between anesthesiologist and surgeon
Article: Acupuncture as a peacekeeper between anesthesiologist and surgeon - Chirurgia 2024 February;37(1):52-3 - Minerva Medica - Journals
- Open Access
Somatic and Abdominal Acupuncture for Pain Treatment in Adolescent Complex Regional Pain Syndrome (CRPS) of the Upper Limb: A Case Report
Complex regional pain syndrome (CRPS) is still poorly understood. It is a pain disorder in which pain is disproportionate to the initial stimulus. There is no specific therapy for CRPS, but it can be managed by a combination of treatments. We report a 13-year-old girl with CRPS of the upper limb treated with somatic and abdominal acupuncture. She described a severe, pulsating pain in the left wrist and hand, with hypersensitivity, allodynia, a marked reduction in strength, and swelling and sweating at the level of the fingers. Pain began three months previously, after a trauma to the left wrist. The diagnostic tests performed were negative. At the first visit we recommended oral tramadol. During the first two sessions we used somatic acupuncture. At the third session, the girl reported suffering intolerable pain in the affected limb during the previous sessions, so we decided to use abdominal acupuncture. After 8 sessions of abdominal acupuncture the pain completely disappeared. Acupuncture could be a potential alternative when conservative therapy with physical and medical treatment fails, but more often parents and adolescents prefer this therapy since other comorbidities are often present in pediatric populations and abdominal acupuncture could be a valuable alternative aid.
Open AccessSomatic and Abdominal Acupuncture for Pain Treatment in Adolescent Complex Regional Pain Syndrome (CRPS) of the Upper Limb: A Case Report
Complex regional pain syndrome (CRPS) is still poorly understood. It is a pain disorder in which pain is disproportionate to the initial stimulus. There is no specific therapy for CRPS, but it can be managed by a combination of treatments. We report a 13-year-old girl with CRPS of the upper limb treated with somatic and abdominal acupuncture. She described a severe, pulsating pain in the left wrist and hand, with hypersensitivity, allodynia, a marked reduction in strength, and swelling and sweating at the level of the fingers. Pain began three months previously, after a trauma to the left wrist. The diagnostic tests performed were negative. At the first visit we recommended oral tramadol. During the first two sessions we used somatic acupuncture. At the third session, the girl reported suffering intolerable pain in the affected limb during the previous sessions, so we decided to use abdominal acupuncture. After 8 sessions of abdominal acupuncture the pain completely disappeared. Acupuncture could be a potential alternative when conservative therapy with physical and medical treatment fails, but more often parents and adolescents prefer this therapy since other comorbidities are often present in pediatric populations and abdominal acupuncture could be a valuable alternative aid.
- Open Access
Incidence of Acute and Chronic Post-Thoracotomy Pain in Pediatric Patients
We studied acute and chronic pain in pediatric patients who underwent thoracotomy for benign disease with a follow-up of at least three months. A telephone interview investigated about the presence of pain and the analgesic therapy in progress. The results were compared with the anesthetic technique, postoperative pain and the adequacy of pain therapy, both during the first week after surgery and at the time of interview. Fifty-six families consented to the study. The mean age of the children at surgery was 2.9 ± 4.5 years, while at the time of the interview was 6.5 ± 4.4 years. We performed different anesthetic strategies: Group A: general anesthesia (36 pts); Group B: general anesthesia and thoracic epidural (10 pts); Group C: general anesthesia and intercostal nerve block (10 pts). During the immediate postoperative period, 21 patients (37.5%) had at least one painful episode. At the time of interview, 3 children (5.3%) had moderate chronic neuropathic (burning) pain on surgical scar. There was no statistically significant difference between the type of anesthesia and the incidence and severity of acute post-operative pain. Despite its limitations, this study confirms the low incidence of chronic post-thoracotomy pain syndrome in children.
Open AccessIncidence of Acute and Chronic Post-Thoracotomy Pain in Pediatric Patients
We studied acute and chronic pain in pediatric patients who underwent thoracotomy for benign disease with a follow-up of at least three months. A telephone interview investigated about the presence of pain and the analgesic therapy in progress. The results were compared with the anesthetic technique, postoperative pain and the adequacy of pain therapy, both during the first week after surgery and at the time of interview. Fifty-six families consented to the study. The mean age of the children at surgery was 2.9 ± 4.5 years, while at the time of the interview was 6.5 ± 4.4 years. We performed different anesthetic strategies: Group A: general anesthesia (36 pts); Group B: general anesthesia and thoracic epidural (10 pts); Group C: general anesthesia and intercostal nerve block (10 pts). During the immediate postoperative period, 21 patients (37.5%) had at least one painful episode. At the time of interview, 3 children (5.3%) had moderate chronic neuropathic (burning) pain on surgical scar. There was no statistically significant difference between the type of anesthesia and the incidence and severity of acute post-operative pain. Despite its limitations, this study confirms the low incidence of chronic post-thoracotomy pain syndrome in children.
- Open Access
- 1 March 2021
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 71 (2) , 201-203
COVID-19 pandemic mental health risks among anesthesiologists: it is not only burnout
- 1 March 2021
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 71 (2) , 201-203
Open AccessCOVID-19 pandemic mental health risks among anesthesiologists: it is not only burnout
- Open Access
- 27 February 2021
- Published by Springer Nature
Incidence of Acute and Chronic Post-Thoracotomy Pain in Children v1
This retrospective cross-sectional study involved patients, at Ospedale Bambino Gesù Children's Hospital in Rome, Italy, who underwent thoracotomy between 2007 and 2013 for benign diseases, with a follow-up of at least three months and who did not reach the age of majority in November 2013. To the families a letter to explain the study, the request for collaboration, a questionnaire for data collection and an informed consent were sent. Fifteen days after, the telephone interview began and we asked them to countersign and send us informed consent via email, fax or post. During the interview we asked about the presence, kind, intensity and location of the pain only at the time of the interview and any analgesic therapy in progress. Using the medical records referring to the period of hospitalization for surgery, we investigated the anesthetic technique used, the postoperative analgesic therapy prescribed, any changes made to it and changes in pain during the first week of the postoperative period. In case of unsuccessful telephone contact, a second letter has been sent. Patients who reached the age of majority in November 2013, patients with malignant and inflammatory diseases, patients who did not have a follow-up of at least three months and patients of whom it was not possible to have an answer after the second letter of presentation were excluded from the study. The subjects removed from the study in case of non-response to the second letter have not been replaced. The prevalence of acute postoperative pain and the prevalence of chronic pain at the time of interview have been described. The adequacy of pain treatment was assessed with the Pain Management Index (PMI) and modified for the use on children. The predictive factors of chronic pain have been explored Categorical variables were summarized using absolute frequencies and percentages, and continuous variables by the mean or median and interquartile range, as appropriate. To determine statistical differences between groups, we used the Chi-square test or Fischer’s exact test for categorical variables and the t-test or Mann–Whitney test for continuous variables. We used Z-test to compare the frequency of postoperative pain. Statistical analyses were carried out using the Stata program, version 13 (2013, Stata statistical software: StataCorp, College Station, TX).
- 27 February 2021
- Published by Springer Nature
Open AccessIncidence of Acute and Chronic Post-Thoracotomy Pain in Children v1
This retrospective cross-sectional study involved patients, at Ospedale Bambino Gesù Children's Hospital in Rome, Italy, who underwent thoracotomy between 2007 and 2013 for benign diseases, with a follow-up of at least three months and who did not reach the age of majority in November 2013. To the families a letter to explain the study, the request for collaboration, a questionnaire for data collection and an informed consent were sent. Fifteen days after, the telephone interview began and we asked them to countersign and send us informed consent via email, fax or post. During the interview we asked about the presence, kind, intensity and location of the pain only at the time of the interview and any analgesic therapy in progress. Using the medical records referring to the period of hospitalization for surgery, we investigated the anesthetic technique used, the postoperative analgesic therapy prescribed, any changes made to it and changes in pain during the first week of the postoperative period. In case of unsuccessful telephone contact, a second letter has been sent. Patients who reached the age of majority in November 2013, patients with malignant and inflammatory diseases, patients who did not have a follow-up of at least three months and patients of whom it was not possible to have an answer after the second letter of presentation were excluded from the study. The subjects removed from the study in case of non-response to the second letter have not been replaced. The prevalence of acute postoperative pain and the prevalence of chronic pain at the time of interview have been described. The adequacy of pain treatment was assessed with the Pain Management Index (PMI) and modified for the use on children. The predictive factors of chronic pain have been explored Categorical variables were summarized using absolute frequencies and percentages, and continuous variables by the mean or median and interquartile range, as appropriate. To determine statistical differences between groups, we used the Chi-square test or Fischer’s exact test for categorical variables and the t-test or Mann–Whitney test for continuous variables. We used Z-test to compare the frequency of postoperative pain. Statistical analyses were carried out using the Stata program, version 13 (2013, Stata statistical software: StataCorp, College Station, TX).